Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) study

Sumit R. Majumdar, Finlay A. McAlister, Marilyn Cree, Wei Ching Chang, Milton Packer, Paul W. Armstrong

Clinical Sciences

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) study'. Together they form a unique fingerprint.

Sort by
Weight
Alphabetically

Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) study

Fingerprint

Medicine & Life Sciences